Genetic Testing is the analysis of DNA, RNA, chromosomes, genes or particular genetic variants to obtain information about a person's inherited biological characteristics or genetic risks. Depending on its purpose, testing can identify a genetic variant responsible for an existing condition, determine whether someone carries a variant that could be passed to children, estimate susceptibility to particular diseases, establish biological relationships or help select and dose certain medicines. The term encompasses many different laboratory techniques rather than one test. Testing can examine a single gene, a defined group of genes, many thousands of genes through sequencing, chromosome structure or particular molecular changes. The appropriate test depends on the clinical or non-clinical question being asked.
Genetic Testing can be used for diagnostic, predictive, carrier, prenatal, newborn-screening, pharmacogenomic and reproductive purposes. Diagnostic testing investigates whether a suspected genetic condition is present in someone who has relevant symptoms or clinical findings. Predictive or presymptomatic testing can identify variants associated with an increased likelihood of developing a condition in the future, although a genetic predisposition does not always mean that disease will develop. Carrier testing identifies people who possess a usually recessive disease-associated variant without themselves having the corresponding disorder. Pharmacogenomic testing examines genetic differences that can influence drug metabolism, response or adverse-effect risk.
Modern Genetic Testing uses several technological approaches. Polymerase chain reaction can amplify selected DNA sequences, microarrays can examine large numbers of predefined genetic markers, and sequencing can determine the order of nucleotide bases in DNA. Sanger sequencing remains useful for targeted analysis, while next-generation sequencing enables simultaneous examination of numerous genes or much larger portions of the genome. Whole-exome sequencing focuses mainly on protein-coding regions, whereas whole-genome sequencing examines nearly the entire genome. Chromosomal analysis can detect large structural abnormalities that may not be captured by a narrowly targeted molecular test.
Genetic variants are interpreted according to their relationship with health and available scientific evidence. A pathogenic variant has sufficient evidence to be associated with disease, whereas a benign variant is not considered disease-causing. Variants of uncertain significance are changes for which available evidence is insufficient to determine their clinical significance. This distinction is essential because detecting a DNA difference does not automatically establish that it causes disease. Some variants have incomplete penetrance, meaning that not everyone carrying the variant develops the associated condition, while variable expressivity means that the manifestations can differ among people carrying the same disease-associated variant.
Genetic Testing can use samples such as blood, saliva, cheek cells or other tissues depending on the assay. The physical collection procedure is generally straightforward, but interpretation can be considerably more complex. A test result can be positive, negative, inconclusive or uncertain, and the meaning of a negative result depends on what the test was capable of detecting. A negative result from a targeted test does not necessarily exclude a genetic condition if another gene or type of variant was not examined. Genetic counselling can help explain the purpose, limitations and potential implications of testing before and after testing, particularly when results may affect relatives or reproductive decisions.
Genetic information has distinctive privacy and ethical considerations because it can reveal information about biological relatives as well as the person tested. Results can sometimes uncover unexpected relationships, identify previously unrecognised familial risks or reveal findings unrelated to the original reason for testing. Laboratories and healthcare systems therefore apply specific procedures concerning consent, data handling, interpretation and reporting. Genetic testing can also produce incidental findings when analysis reveals medically important variants unrelated to the original clinical question. The significance of such findings depends on the test, reporting framework and circumstances in which testing was performed.
Genetic Testing differs from ordinary laboratory testing because genetic information often describes relatively stable biological characteristics rather than a temporary physiological state. A blood glucose measurement can change substantially over hours, whereas an inherited DNA sequence generally remains unchanged throughout life, although gene expression and acquired genetic changes can vary. Genetic tests can also identify familial implications because inherited variants may be shared by biological relatives. However, genetics is only one component of disease risk. Environmental exposures, lifestyle, age, chance biological events and interactions among many genes can all influence whether a disease develops.
The limitations of Genetic Testing are as important as its capabilities. A technically accurate test can still be clinically misleading if it is ordered for the wrong question, interpreted without appropriate population data or used without considering the person's symptoms and family history. Some conditions are caused by variants that current technologies cannot detect reliably, while other conditions involve complex interactions among many genes and environmental factors that are difficult to predict from DNA alone. Results can also change in interpretation as scientific knowledge develops. Genetic Testing is therefore most useful when the specific test, analytical limitations, clinical context and implications of the result are understood together.
